These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Small molecule inducers of actinobacteria natural product biosynthesis. Alwali AY; Parkinson EI J Ind Microbiol Biotechnol; 2023 Feb; 50(1):. PubMed ID: 37587009 [TBL] [Abstract][Full Text] [Related]
49. Heterologous production of new lanthipeptides hazakensins A and B using a cryptic gene cluster of the thermophilic bacterium Thermosporothrix hazakensis. Kaweewan I; Ijichi S; Nakagawa H; Kodani S World J Microbiol Biotechnol; 2022 Nov; 39(1):30. PubMed ID: 36445498 [TBL] [Abstract][Full Text] [Related]
50. Targeted Discovery of Cryptic Metabolites with Antiproliferative Activity. Han EJ; Lee SR; Hoshino S; Seyedsayamdost MR ACS Chem Biol; 2022 Nov; 17(11):3121-3130. PubMed ID: 36228140 [TBL] [Abstract][Full Text] [Related]
51. Potential of marine natural products against drug-resistant bacterial infections. Liu M; El-Hossary EM; Oelschlaeger TA; Donia MS; Quinn RJ; Abdelmohsen UR Lancet Infect Dis; 2019 Jul; 19(7):e237-e245. PubMed ID: 31031171 [TBL] [Abstract][Full Text] [Related]
52. Inducing Global Expression of Actinobacterial Biosynthetic Gene Clusters. Pepler MA; Zhang X; Hindra ; Elliot MA Methods Mol Biol; 2022; 2489():157-171. PubMed ID: 35524050 [TBL] [Abstract][Full Text] [Related]
53. The re-emerging role of microbial natural products in antibiotic discovery. Genilloud O Antonie Van Leeuwenhoek; 2014 Jul; 106(1):173-88. PubMed ID: 24923558 [TBL] [Abstract][Full Text] [Related]
54. Present and future outlooks on environmental DNA-based methods for antibiotic discovery. Rosenzweig AF; Burian J; Brady SF Curr Opin Microbiol; 2023 Oct; 75():102335. PubMed ID: 37327680 [TBL] [Abstract][Full Text] [Related]
55. Isolation and identification of endophytic actinobacteria from Citrullus colocynthis (L.) Schrad and their antibacterial properties. Ali AR; Bahrami Y; Kakaei E; Mohammadzadeh S; Bouk S; Jalilian N Microb Cell Fact; 2022 Oct; 21(1):206. PubMed ID: 36217205 [TBL] [Abstract][Full Text] [Related]
56. Structure and biosynthesis of xenoamicins from entomopathogenic Xenorhabdus. Zhou Q; Grundmann F; Kaiser M; Schiell M; Gaudriault S; Batzer A; Kurz M; Bode HB Chemistry; 2013 Dec; 19(49):16772-9. PubMed ID: 24203528 [TBL] [Abstract][Full Text] [Related]
57. The Impending Renaissance in Discovery & Development of Natural Products. Pawar SV; Ho JC; Yadav GD; Yadav VG Curr Top Med Chem; 2017; 17(2):251-267. PubMed ID: 27237327 [TBL] [Abstract][Full Text] [Related]
58. Naturally Occurring Peptides from Rana temporaria: Antimicrobial Properties and More. Mangoni ML; Grazia AD; Cappiello F; Casciaro B; Luca V Curr Top Med Chem; 2016; 16(1):54-64. PubMed ID: 26139114 [TBL] [Abstract][Full Text] [Related]
59. Analysis of modular bioengineered antimicrobial lanthipeptides at nanoliter scale. Schmitt S; Montalbán-López M; Peterhoff D; Deng J; Wagner R; Held M; Kuipers OP; Panke S Nat Chem Biol; 2019 May; 15(5):437-443. PubMed ID: 30936500 [TBL] [Abstract][Full Text] [Related]
60. Bacterial pathogens: threat or treat (a review on bioactive natural products from bacterial pathogens). Maglangit F; Yu Y; Deng H Nat Prod Rep; 2021 Apr; 38(4):782-821. PubMed ID: 33119013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]